Can AI Learn to Smell Disease? A New Dataset Paves the Way
Researchers are developing a large-scale olfactory dataset to train artificial intelligence, potentially unlocking smell as a powerful tool for early disease detection.
Read MorePosted by CLP Edit Staff | Oct 9, 2025 | Diagnostic Technologies |
Researchers are developing a large-scale olfactory dataset to train artificial intelligence, potentially unlocking smell as a powerful tool for early disease detection.
Read MorePosted by CLP Edit Staff | Oct 1, 2025 | Lung Cancer |
A new blood-based test that combines four protein markers with artificial intelligence has demonstrated potential for early lung cancer detection in a multicenter retrospective study.
Read MorePosted by Alyx Arnett | Sep 29, 2025 | Cancer |
First Ascent Biomedical is validating a live-cell testing platform that screens over 150 FDA-approved therapies against a patient’s tumor, generating individualized treatment insights in about 10 days.
Read MorePosted by CLP Edit Staff | Sep 26, 2025 | Sequencing Systems |
New research demonstrates the ultra-sensitive SNV detection capabilities of ppmSeq technology, with error rates reaching as low as 8 x 10-8 for minimal residual disease applications.
Read MorePosted by Alyx Arnett | Sep 25, 2025 | Lung Cancer |
On World Lung Day, Reveal Dx board member Mat Brevard discusses why current diagnostic tools fall short—and how new approaches could improve accuracy and outcomes.
Read More